GRANTS
- GRANTInvestigation of the Effects of Three JAK Inhibitors on Cytokine Production and Signaling in Peripheral Blood Mononuclear Cells of DogsAmerican College of Vet Dermatology12 Jan 2026 - 15 Feb 2027
- GRANTCarus Animal Health_NexabiomeCarus Animal Health Limited2 Jul 2025 - 14 Dec 2027
- GRANTCharacterization of Antibodies against Equine IL-31Grayson Jockey Club Research Foundation22 May 2025 - 31 May 2027
- GRANTPilot study to assess the clinical efficacy of immune Ig and anti-idiotypic Ig in dogs with allergic skin diseasesNetwork Immunology17 Dec 2024 - 1 Feb 2027
- GRANTPhase II - The JILL Study Argenta Merck - Protocol Number S21068-00: Evaluation of field safety and effectiveness of a novel oral JAK-1 inhibitor (AH386526 30 mg/g oral tablets for dogs) compared to active control for the control of atopic dermatitis in dMerck Animal Health25 Apr 2024 - 27 Mar 2026
- GRANTProtocol Number S21069-00: Evaluation of field safety and effectiveness of a novel oral JAK-1 inhibitor (AH386526 30 mg/g oral tablets for dogs) compared to placebo control for the control of pruritus associated with allergic dermatitis in dogs.Merck Animal Health28 Apr 2023 - 27 Apr 2024
- GRANTD23CA-012: Investigation of Prevention Strategies and Treatment Options of Otitis in DogsMorris Animal Foundation28 Feb 2023 - 30 Apr 2027
- GRANTDevelopment of a biologic against equine IL-31American College of Vet Dermatology23 Dec 2021 - 14 Feb 2023
- GRANTThe effect of probiotic vs. placebo on the clinical response and cytokine profile in felines with allergic dermatitis: a randomized, double blinded controlled study.16 Jun 2021 - 15 Feb 2024
- GRANTEffect of supplement on skin lipid concentration in healthy dogsNutramax Laboratories Veterinary Science28 Jul 2020 - 15 Sep 2021
- GRANTTopical bacteriophage therapy for staphylococcal superficial pyoderma in horses: a proof of concept study13 Jul 2020 - 30 Jun 2021
- GRANTTopical bacteriophage therapy for staphylococcal superficial pyoderma in horses: a pilot studyAus and Nzl College of Vet Scientists3 Jul 2020 - 1 Jun 2023
- GRANTThe Development of a Protocol for Evaluating Probiotic Treatment of Canine Atopic DermatitisArcher Daniels Midland Company21 May 2020 - 30 Apr 2021
- GRANTInvestigation of the role of IL-33 on atopic dermatitisScout Bio4 Dec 2019 - 31 Oct 2020
- GRANTInvestigation of OKV-1001, an extended release mycophenolic acid, in a canine model of atopic dermatitis.Okava Pharmaceuticals29 May 2019 - 30 Apr 2020
- GRANTGenetics analysis of an established colony of laboratory beagles with atopic dermatitisAmerican College of Vet Dermatology20 Feb 2019 - 31 Aug 2021
- GRANTOclacitinib and its role on dendritic cell cytokine release in atopic and normal dogs, in vitro, a pilot studyAmerican College of Vet Dermatology1 Sep 2018 - 29 Feb 2020
- GRANTDetermination of effects of topical WOL071-308 in a colony of atopic BeaglesDr August Wolff Gmbh & Corporation Kg Arzneimitte16 Aug 2018 - 23 Aug 2020
- GRANTPilot study to evaluate the clinical efficacy of Donepezil to decrease signs of atopic dermatitis in an experimental model using high IgE producing BeaglesNeuroderma29 Mar 2017 - 14 Mar 2018
- GRANTPilot Study using microencapsulated Diindolylmethane (DIM) to modulate the inflammatory response in a canine model of atopic dermatitisBioresponse LLC9 Aug 2016 - 6 Jun 2018
- GRANTPILOT STUDY TO EVALUATE THE EFFECTS OF AN ORAL SUPPLEMENT ON SKIN BARRIER FUNCTIONBioiberica S A1 Jul 2016 - 7 Aug 2017
- GRANTPILOT INVESTIGATIONS ON THE EFFECTS OF A JAK1/2 INHIBITOR ONSKIN BARRIER FUNCTIONUF Foundation12 May 2016 - 31 Mar 2018
- GRANTDetermination of Effects of WOL067-531, a Modulator of the Endocannabinoid System, in a Canine Animal Model of Atopic Dermatitis BeaglesDr August Wolff Gmbh & Corporation Kg Arzneimitte11 Apr 2016 - 20 Mar 2017
- GRANTAugust Wolff Consulting AgreementDr August Wolff Gmbh & Corporation Kg Arzneimitte29 Mar 2016 - 20 Jan 2017
- GRANTA study to evaluate the clinical efficacy of SAR346923BMerial (USA)21 Dec 2015 - 30 Jun 2016